Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
PBS/Acyl-GIP, n = 8, GIPR Antag/Acyl-GIP, n = 7
This modification reversibly increases binding to albumin, which results in protection of liraglutide from degradation by DPP-4 and reduces renal clearance
The carrier materials used for nanoparticles are typically biodegradable or ion sensitive and exhibit low toxicity, minimal side effects, and controllable release characteristics
Bromfield EG, Walters JLH, Cafe SL, Bernstein IR, Stanger SJ, Anderson AL, et al
US$ 22.05
US$ 23.76
US$ 20.33
